Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 9:49 AM UTC
| NCT Number | NCT06106945 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE1 |
| Target Enrollment | 226 participants |
| Active Locations | 9 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | August 19, 2026 (Aug 19, 2026) |
As of October 16, 2026: Clinical trial NCT06106945 is currently recruiting participants. This phase1 study for multiple myeloma is actively seeking new participants at 9 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06106945 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06106945 was last updated Aug 19, 2026 (August 19, 2026). HelloStudys verifies this status automatically.